restructuring plan, page-11

Auto,

Didn't you vote yes for biota moving to the US?

Any success in RSV, Lani or HRV pipeline will bring Biota to a new level.

So does biota still need that many juniors doing daily testing on mice?


The company further focus on its late stage pipelines. That is good. Cap raising or financing for the right pipelines will be much easier and cheaper.

If BOTA still have high research cost, no one would like to lend the company money. Clearly, you would not, right?


Just my thoughts.